Table 4.
Neoplasm (n [%]) | Belatacept (n = 102) | CsA (n = 26) |
---|---|---|
Nonmelanoma skin cancers | 9 (9)a | 2 (8) |
Kaposi sarcoma | 1 (1) | 0 (0) |
Breast cancer | 2 (2) | 0 (0) |
Prostate cancer | 1 (1) | 0 (0) |
Malignant melanoma | 1 (1) | 0 (0) |
PTLD | 0 (0) | 1 (4) |
aOne patient had both squamous cell carcinoma and malignant melanoma, and one patient had squamous cell carcinoma and two occurrences of basal cell carcinoma.